Nahdi Medical Reports SAR 450.90M Net Profit in the Six Months 2026
NAHDI 4164.SA | 0.00 |
On 2026-07-29 08:03:13 (Saudi Time), Nahdi Medical Co. announced its Interim financial results for the six months ended on June 30, 2026.
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 2,674.3 | 2,527.6 | 5.803 | 2,794.4 | -4.297 |
| Gross Profit (Loss) | 1,007.6 | 966 | 4.306 | 987.7 | 2.014 |
| Operational Profit (Loss) | 245.9 | 260.6 | -5.64 | 259.7 | -5.313 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 215.2 | 238.4 | -9.731 | 235.7 | -8.697 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 234 | 239.4 | -2.255 | 262.1 | -10.721 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 5,468.7 | 5,162.5 | 5.931 |
| Gross Profit (Loss) | 1,995.4 | 1,909.8 | 4.482 |
| Operational Profit (Loss) | 505.6 | 530.6 | -4.711 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 450.9 | 493.6 | -8.65 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 496.2 | 492.4 | 0.771 |
| Total Shareholders Equity (after Deducting Minority Equity) | 2,511.7 | 2,688.5 | -6.576 |
| Profit (Loss) per Share | 3.47 | 3.8 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
Year-on-Year Performance Drivers
For the six-month period ending 30 June 2026, Nahdi Medical Company's revenue grew 5.931% YoY to SAR 5,468.7 million (vs. SAR 5,162.5 million), driven by a 4.4% increase in the Retail business across Pharma and Front Shop segments, alongside strong growth of 34.6% in Healthcare and 28% in regional expansion businesses. Despite the revenue growth, net profit attributable to shareholders declined 8.65% YoY to SAR 450.9 million (vs. SAR 493.6 million), as higher operating expenses related to strategic growth initiatives, healthcare expansion, and digital capabilities weighed on operating profit, which fell 4.711% to SAR 505.6 million, while gross margin also compressed slightly to 36.5% from 37.0% due to a shift in business mix toward lower-margin segments. Additionally, items below operating profit reflected a net increase in expenses of SAR 17.6 million, further pressuring the bottom line.
Quarter-on-Quarter Performance Drivers
QoQ revenue declined 4.3% to SAR 2,674.3 million from SAR 2,794.4 million in the prior quarter, primarily driven by seasonality as Q1 benefited from a sales uplift associated with the Ramadan season. Net profit fell 8.697% QoQ to SAR 215.2 million from SAR 235.7 million, with no further detailed breakdown provided beyond the revenue-driven decline.
Other Items
Nahdi Medical Co.'s external auditor issued an unmodified conclusion for the interim period ending 30 June 2026, with no additional comments noted in any other matter, conservation, notice, disclaimer of opinion, or adverse opinion paragraphs. No material risks or going concern issues were flagged. Total shareholders' equity (after deducting minority equity) stood at SAR 2,511.7 million as of the current period, compared to SAR 2,688.5 million in the same period of the prior year, a decline of 6.576%. Earnings per share for the current period were SAR 3.47, compared to SAR 3.8 in the same period last year. Certain comparative information has been reclassified to align with the current period presentation ending 30 June 2026. Other Comprehensive Income increased due to a decrease in actuarial expense resulting from a re-assessment of the actuarial estimate for end-of-service indemnity. The Company also noted that, in accordance with its governance, it strictly adheres to Shariah principles in all areas of its business, including banking and investment activities, and as a result, all costs incurred and revenues generated from these activities are Shariah-compliant.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=97047&anCat=1&cs=4164&locale=arAttached PDF document link:
https://www.saudiexchange.sa/Resources/fsPdf/17555_2964_2026-07-28_20-28-26_en.pdfImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.
